Sino Biopharmaceutical Stock Forecast

Stock Price Forecast

According to 21 analysts polled by S&P Global, Sino Biopharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $8.91. The average 1-year stock price forecast is 78.56% higher than the current stock price, while the lowest is $7.14 (+43.09%) and the highest is $10.58 (+112.02%).

Price Target: $8.91 (+78.56%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.14	$8.91	$9.05	$10.58
Change	+43.09%	+78.56%	+81.36%	+112.02%

Analyst Ratings

The average analyst rating for Sino Biopharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	20	20	18	18	17	17
Buy	5	5	5	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	26	26	24	22	21	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mark Kong CFA DBS	DBS	Buy Initiates $6.50	Buy	Initiates	$6.50	+30.26%	May 20, 2026
Chu Wang Jefferies	Jefferies	Buy Maintains $7.00	Buy	Maintains	$7.00	+40.28%	Mar 31, 2026
Unknown Analyst BOCOM International Holdings Company No rating	BOCOM International Holdings Company	Buy Maintains $8.50 → $7.70	Buy	Maintains	$8.50 → $7.70	+54.31%	Mar 31, 2026
Jill Wu CMB International Securities	CMB International Securities	Buy Maintains $8.70	Buy	Maintains	$8.70	+74.35%	Mar 31, 2026
Unknown Analyst Citic Securities No rating	Citic Securities	Buy Maintains $9.00	Buy	Maintains	$9.00	+80.36%	Mar 30, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.